STOCK TITAN

Tilray Brands Inc - TLRY STOCK NEWS

Welcome to our dedicated news page for Tilray Brands (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on Tilray Brands.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Tilray Brands's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Tilray Brands's position in the market.

Rhea-AI Summary
Breckenridge Distillery Announces Limited-Edition Back-to-Back Broncos Bourbon Blends and Broncos Vodka in Partnership with Denver Broncos
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.39%
Tags
partnership
-
Rhea-AI Summary
Tilray Brands to acquire eight beer and beverage brands from Anheuser-Busch, becoming the 5th largest craft beer brewer in the US with 5% market share. Pro forma revenue expected to be ~$300 million, accretive to EBITDA. Transaction to close in 2023. Tilray aims to drive revenue and cost synergies, expand distribution, and invest in the craft beer industry. Beer business expected to triple in size to 12 million cases annually. Positive for Tilray's growth strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
36.04%
Tags
-
Rhea-AI Summary
Montauk Brewing Company announces distribution partnership with Origlio Beverage and Banko Beverage to bring its craft beers to Pennsylvania, including Philadelphia, Scranton, and the Lehigh Valley.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.42%
Tags
none
Rhea-AI Summary
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) and Great North Distributors, Inc. announced a renewed national brokerage agreement, solidifying Great North as the exclusive representative for Tilray's recreational cannabis products in Canada (excluding Quebec). Great North will invest in dedicated resources and enhanced data capabilities to maximize sales revenue, further driving exceptional route-to-market efficiencies for Tilray's market-leading cannabis portfolio, including newly acquired HEXO brands.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.88%
Tags
none
-
Rhea-AI Summary
Tilray Brands reported record Q4 net revenue of $184 million, representing 20% YoY growth. FY2023 net revenue was $627 million, with a 6% growth to $668 million on a constant currency basis. The company achieved nearly $200 million improvement in adjusted free cash flow compared to FY2022. Tilray increased its cannabis market share position in Canada to 13% with the HEXO acquisition and grew its medical cannabis market position across Europe. The company issued FY2024 guidance with adjusted EBITDA targets of $68 million to $78 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.88%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.78%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.82%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.82%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.49%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.25%
Tags
none
Tilray Brands Inc

Nasdaq:TLRY

TLRY Rankings

TLRY Stock Data

1.41B
770.48M
1.33%
10.98%
15.42%
Medicinal and Botanical Manufacturing
Manufacturing
Link
Canada
Nanaimo

About TLRY

tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.